CONCLUSION
Patients with ICM presenting with VT undergoing first-line VT ablation have a significant lower rate of appropriate ICD therapies without a mortality difference compared to patients receiving an initial approach based on medical therapy. The beneficial effect in improved survival-free from VT/VF and appropriate ICD therapies was seen only in patients with moderately depressed LVEF. First-line VT ablation should be considered the therapeutic approach of choice in this selected group of patients to improve clinical outcomes.